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● Normal periodontal tissue - homeostasis 
is maintained by bone resorbing 
osteoclasts
● Patients with osteoporosis - impaired 
homeostasis
● NF-KB Ligand (RANKL)
● Osteoblasts produce osteoprotegerin 
(OPG)
● **OPG is protective against bone loss** https://www.medicinenet.com/osteop
orosis/article.htm





- 3 carboxylic acids
Taken up by acid-secreting 
osteoclasts
Induces apoptosis in these cells
Inhibits bone resorption
Previous Study
Periodontal disease was induced in OPG KO mouse model and found 
intraperitoneally administered RMA inhibited alveolar bone 
resorption
Researchers wanted to see if RMA could be administered 
non-invasively through the mouth




been removed from 
mice)
RMA - reveromycin A
Intraperitoneally - 
through the stomach
Question to be answered:
Does RMA ointment reduce the number of osteoclasts and 
inhibit bone resorption in mice with periodontal disease?
RMA - reveromycin A
Materials and Methods
- 64, 8-week old male wild type and OPG KO experimented on in 
temperature maintained conditions with constant light cycles. 
They had free access to food and water
- Periodontal diseased mice were prepared through ligation by 
placing wire as shown: 




been removed from 
mice)
RMA - reveromycin A
Ligation - surgical 
closing off of blood 
vessel
- Silicone -based ointment with 1% 
RMA was used 
- Same ointment without RMA was 
used for control group
- Ointment was applied three times 
daily at: 
RMA - reveromycin A
Experimental Groups
WC OC
WT and OPG KO 
mice without 
ligature or RMA
WT - wild type




been removed from 
mice)
RMA - reveromycin A
Ligation - surgical 
closing off of blood 
vessel
WR-  OR-
WT and OPG KO 
mice with ligature 
and without RMA
WR+  OR+
WT and OPG KO 
mice with ligature 
and RMA
Ligation - surgical 
closing off of blood 
vessel
- Mice were sacrificed 8 weeks after ligature
- Samples were examined using micro-computed 
tomography (u-CT)
- Alveolar bone volume was analyzed using TRI/3D BON 
software
- % of remaining alveolar bone was calculated as shown: 
Maxilla - upper fixed 
bone of jaw
H&E - provides 
detailed view of the 
tissue
TRAP - checks for 
reduced resorptive 
activity
- Maxillae were collected and fixed in 10% neutral buffered 
formalin, then decalcified in 10% EDTA for 4 weeks
- Paraffin blocks were prepared and tissue observation 
sites were selected based on where molar roots were 
found
- Hematoxylin-eosin (H&E) staining was performed 
- % attachment was determined using: 
- TRAP stain was also performed
Tnf-a and IL-1B - used 
for checking cell 
responses (like 
apoptosis)
- Tnf-a and IL-1B immunostaining was performed
- Stained sections were scored as follows:
- 1 (0-20% positive staining)
- 2 (21-40% positive staining)
- 3 (41-60% positive staining)
- 4 (>60% positive staining)
- Slides were evaluated by 2 different examiners
- 4 groups - ointment free, peroral administration, local 
administration with non-RMA ointment, local 
administration with RMA ointment
- WT and OPG KO mice used
- Blood samples collected and TRAP concentrations were 
measured using ELISA kit
Side Question: Does swallowing excess RMA 
ointment have an effect?
WT - wild type




been removed from 
mice)
RMA - reveromycin A








WC and OC - wild 
type and OPG KO 
mice w/o ligation or 
RMA
WR- and OR- : wild 
type and OPG KO 
mice w/ ligation and 
w/o RMA
WR+ and OR+: wild 
type and OPG KO 






H&E - provides 
detailed view of the 
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WC and OC - wild 
type and OPG KO 
mice w/o ligation or 
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WR- and OR- : wild 
type and OPG KO 
mice w/ ligation and 
w/o RMA
WR+ and OR+: wild 
type and OPG KO 




WC and OC - wild 
type and OPG KO 
mice w/o ligation or 
RMA
WR- and OR- : wild 
type and OPG KO 
mice w/ ligation and 
w/o RMA
WR+ and OR+: wild 
type and OPG KO 





Tnf-a and IL-1B - used 
for checking cell 
responses (like 
apoptosis)
WC and OC - wild 
type and OPG KO 
mice w/o ligation or 
RMA
WR- and OR- : wild 
type and OPG KO 
mice w/ ligation and 
w/o RMA
WR+ and OR+: wild 
type and OPG KO 
mice w/ ligation and 
RMA
Results of side 
question





LA - topical 
administration
Discussion
WR+ and OR+ had smaller attachment 
loss than WR- and OR-
RMA ointment reduced immunostaining 
scores of TNF-a and IL-1B
RMA-containing ointment inhibited alveolar 
bone resorption and alleviated periodontal 
disease progression
RMA locally suppressed inflammation
- RMA ointment suppressed localized inflammation and alveolar bone resorption and 
decreased osteoclast count to a similar degree as it had when administered 
peritoneally
- These results suggest the effectiveness of RMA in treating patients with vulnerable 
periodontal tissue due to periodontitis and osteoporosis
What’s currently being used and why is RMA better?
Final Conclusion
The study shows that RMA is an effective 
non-invasive treatment for:
- Preventing periodontitis
- Inhibiting alveolar bone resorption locally 
Link:: https://www.sciencedirect.com/science/article/pii/S1347861321000530
